The Antidiabetic Agent Sodium Tungstate Activates Glycogen Synthesis through an Insulin Receptor-independent Pathway
Open Access
- 1 October 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (44), 42785-42794
- https://doi.org/10.1074/jbc.m308334200
Abstract
Sodium tungstate is a powerful antidiabetic agent when administered orally. In primary cultured hepatocytes, tungstate showed insulin-like actions, which led to an increase in glycogen synthesis and accumulation. However, this compound did not significantly alter the insulin receptor activation state or dephosphorylation rate in cultured cells (CHO-R) or in primary hepatocytes, in either short or long term treatments. In contrast, at low concentrations, tungstate induced a transient strong activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) after 5–10 min of treatment, in a similar way to insulin. Moreover, this compound did not significantly delay or inhibit the dephosphorylation of ERK1/2. ERK1/2 activation triggered a cascade of downstream events, which included the phosphorylation of p90rsk and glycogen synthase-kinase 3β. Experiments with a specific inhibitor of ERK1/2 activation and kinase assays indicate that these proteins were directly involved in the stimulation of glycogen synthase and glycogen synthesis induced by tungstate without a direct involvement of protein kinase B (PKB/Akt). These results show a direct involvement of ERK1/2 in the mechanism of action of tungstate at the hepatic level.Keywords
This publication has 38 references indexed in Scilit:
- Inhibition of Bacteriophage λ Protein Phosphatase by Organic and Oxoanion InhibitorsBiochemistry, 2001
- Protein Kinase C Modulates the Insulin-Stimulated Increase in Akt1 and Akt3 Activity in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1998
- Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulinFEBS Letters, 1998
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- Insulin Stimulation of Mitogen-activated Protein Kinase, p90 , and p70 S6 Kinase in Skeletal Muscle of Normal and Insulin-resistant MicePublished by Elsevier BV ,1995
- Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH/3T3 CellsPublished by Elsevier BV ,1995
- The α‐isoform of glycogen synthase kinase‐3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase‐activated protein kinase‐1 in vitroFEBS Letters, 1994
- Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cationBiochemistry, 1992
- Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucoseFEBS Letters, 1977
- Transition metal ion inhibition of enzyme-catalyzed phosphate ester displacement reactionsJournal of the American Chemical Society, 1974